Your browser doesn't support javascript.
loading
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.
Gonzalez, D; Melloni, C; Yogev, R; Poindexter, B B; Mendley, S R; Delmore, P; Sullivan, J E; Autmizguine, J; Lewandowski, A; Harper, B; Watt, K M; Lewis, K C; Capparelli, E V; Benjamin, D K; Cohen-Wolkowiez, M.
Afiliación
  • Gonzalez D; 1] Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA [2] Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Melloni C; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Yogev R; Ann and Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Poindexter BB; Department of Pediatrics, Riley Hospital for Children, Indiana University, Indianapolis, Indiana, USA.
  • Mendley SR; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Delmore P; Department of Pediatrics, Wesley Medical Center, Wichita, Kansas, USA.
  • Sullivan JE; Kosair Charities Pediatric Clinical Research Unit, Department of Pediatrics, University of Louisville, Louisville, Kentucky, USA.
  • Autmizguine J; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Lewandowski A; EMMES Corporation, Rockville, Maryland, USA.
  • Harper B; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Watt KM; 1] Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA [2] Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Lewis KC; OpAns, Durham, North Carolina, USA.
  • Capparelli EV; Department of Pediatrics, University of California, San Diego, California, USA.
  • Benjamin DK; 1] Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA [2] Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Cohen-Wolkowiez M; 1] Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA [2] Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Clin Pharmacol Ther ; 96(4): 429-37, 2014 Oct.
Article en En | MEDLINE | ID: mdl-24949994
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clindamicina / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Clin Pharmacol Ther Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clindamicina / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Clin Pharmacol Ther Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos